The global infection control supplies market is projected to grow from $58.5 billion in 2026 to $106.1 billion by 2035 as healthcare systems invest more heavily in infection prevention, sterilization technologies, PPE, and automated disinfection solutions. Driven by rising healthcare-associated infections, aging populations, chronic disease burden, and increasing regulatory pressure, the market is evolving toward smarter, technology-enabled infection prevention strategies across hospitals, ambulatory surgical centers, and outpatient care settings.
